- Company List - V
- VVOS
Insider Trading activities at Vivos Therapeutics, Inc. (VVOS)
Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Vivos Therapeutics, Inc. (VVOS)
since 2020 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Vivos Therapeutics, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1716166.
Total stock buying since 2020: $136,170.
Total stock sales since 2020: $0.
Total stock option exercises since 2020: $0.
Table 1. Yearly summary of insider stock purchases, sales, and option exercises
at Vivos Therapeutics, Inc. (VVOS).
|
Insider Buying |
Insider Sales |
Option Exercises |
| Year |
Shares | Value |
Shares | Value |
Shares | Value |
| 2023 | 39,021 | $20,355 | 0 | $0 | 0 | $0 |
| 2022 | 32,000 | $33,559 | 0 | $0 | 0 | $0 |
| 2021 | 15,000 | $63,359 | 0 | $0 | 0 | $0 |
| 2020 | 2,500 | $18,897 | 0 | $0 | 0 | $0 |
Table 2. Monthly summary of insider trading at Vivos Therapeutics, Inc. (VVOS).
| Trading Period |
Insider Buying |
Insider Sales |
Option Exercises |
| year-month |
Shares | Value |
Shares | Value |
Shares | Value |
| 2023-06 | 39,021 | $20,355 | 0 | $0 | 0 | $0 |
| 2022-12 | 20,000 | $10,000 | 0 | $0 | 0 | $0 |
| 2022-06 | 4,000 | $7,320 | 0 | $0 | 0 | $0 |
| 2022-05 | 8,000 | $16,239 | 0 | $0 | 0 | $0 |
| 2021-09 | 5,000 | $21,549 | 0 | $0 | 0 | $0 |
| 2021-08 | 5,000 | $15,000 | 0 | $0 | 0 | $0 |
| 2021-05 | 5,000 | $26,810 | 0 | $0 | 0 | $0 |
| 2020-12 | 2,500 | $18,897 | 0 | $0 | 0 | $0 |
Table 3. Detailed insider trading at Vivos Therapeutics, Inc. (VVOS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2023-06-20 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 14,000 | .53 | 7,420 |
| 2023-06-16 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 15,000 | .54 | 8,025 |
| 2023-06-15 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 21 | .50 | 10 |
| 2023-06-14 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 10,000 | .49 | 4,900 |
| 2022-12-23 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 20,000 | .50 | 10,000 |
| 2022-06-01 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 4,000 | 1.83 | 7,320 |
| 2022-05-31 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 8,000 | 2.03 | 16,239 |
| 2021-09-21 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 5,000 | 4.31 | 21,549 |
| 2021-08-17 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 5,000 | 3.00 | 15,000 |
| 2021-05-25 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 4,000 | 5.38 | 21,520 |
| 2021-05-25 | Amman Bradford K. (Chief Financial Officer) | Buy | 1,000 | 5.29 | 5,290 |
| 2020-12-24 | Amman Bradford K. (Chief Financial Officer) | Buy | 1,000 | 7.38 | 7,380 |
| 2020-12-23 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 1,000 | 7.27 | 7,267 |
| 2020-12-11 | Huntsman Ronald Kirk (Chief Executive Officer) | Buy | 500 | 8.50 | 4,250 |
Insider trading activities including stock purchases, stock sales, and option exercises
of VVOS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Vivos Therapeutics, Inc. (symbol VVOS,
CIK number 1716166) see
the Securities and Exchange Commission (SEC) website.